Highlights

Koon Yew Yin's Blog

Author: Koon Yew Yin   |   Latest post: Tue, 22 Sep 2020, 3:42 PM

 

Investors misled by Russian Covid 19 vaccine - Koon Yew Yin

Author:   |    Publish date:


Many investors were misled by Russian President Putin’s announcement that his daughter has been injected with the vaccine discovered by Russian scientists. As a result, they rushed to sell all the glove stocks. Top Glove and Supermax dropped more than 10% within the last 2 days.

Fortunately, many smart investors realised that Putin is just a clever politician and wanted publicity. Putin’s daughter may soon die. As investors, they can see that the Covid 19 pandemic is still spreading like wild fire. In fact, many scientists predicted that Covid 19 will not be under control for at least 1 or more years.

Many smart investors started buying aggressively this morning to push the share prices higher and higher.

Those short-sighted sellers are now in a dilemma- to buy back at higher prices or not miss this golden opportunity to make more money.

You must read how and why it is so important that the vaccine has to undergo phase 3 testing.

According to The New York Times Coronavirus Vaccine Tracker, there are currently 8 vaccines in large-scale Phase 3 efficacy tests. Typically, Phase 3 trials are large enough to reveal any evidence of rare, potentially life-threatening side effects. The FDA has said a COVID-19 vaccine will need to protect at least 50 percent of vaccinated persons to receive agency approval in the United States. 

Researchers around the world are developing more than 165 vaccines against the coronavirus, and 30 vaccines are in human trials. Vaccines typically require years of research and testing before reaching the clinic, but scientists are racing to produce a safe and effective vaccine by next year.

 

PRECLINICAL TESTING: Scientists give the vaccine to animals such as mice or monkeys to see if it produces an immune response.

PHASE 1 SAFETY TRIALS: Scientists give the vaccine to a small number of people to test safety and dosage as well as to confirm that it stimulates the immune system.

PHASE 2 EXPANDED TRIALS: Scientists give the vaccine to hundreds of people split into groups, such as children and the elderly, to see if the vaccine acts differently in them. These trials further test the vaccine’s safety and ability to stimulate the immune system.

PHASE 3 EFFICACY TRIALS: Scientists give the vaccine to thousands of people and wait to see how many become infected, compared with volunteers who received a placebo. These trials can determine if the vaccine protects against the coronavirus. In June, the F.D.A. said that a coronavirus vaccine would have to protect at least 50% of vaccinated people to be considered effective. In addition, Phase 3 trials are large enough to reveal evidence of relatively rare side effects that might be missed in earlier studies.

APPROVED: Regulators in each country review the trial results and decide whether to approve the vaccine or not. During a pandemic, a vaccine may receive emergency use authorization before getting formal approval. Once a vaccine is licensed, researchers continue to monitor people who receive it to make sure it’s safe and effective.

 
 

 

 

 

Share this

APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

525  363  569  632 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MTRONIC 0.085+0.005 
 ASB 0.17-0.02 
 MNC 0.045-0.005 
 HLT 1.67+0.14 
 KANGER 0.235-0.025 
 MTOUCHE 0.065-0.005 
 VSOLAR 0.040.00 
 CAREPLS 3.15+0.33 
 MMAG-WB 0.13-0.04 
 TOPGLOV 8.55+0.53 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!
PARTNERS & BROKERS